Rivaroxaban

Latest: Acute kidney injury (AKI) in England in 2018 [news]
Latest: AKI and Covid-19 [news]
Latest: COVID-19 – recent podcasts [news]
Latest: COVID-19 and ACE Inhibitor/Angiotensin Receptor Blocker use [news]
Latest: AKI Post-discharge Guidance [news]
Latest: Acute Kidney Injury Toolkit for GP’s and healthcare professionals [news]

AKI Home
About
Case studies
- Local QI
AKI data
Resources
Public Info

Menu

AKI Home
About us
Case studies
AKI data
Resources
Renal Association Quality Improvement Team Privacy Notice

A drug – an oral anticoagulant

News
Blog
Key messages
Newsletter
Webinars

Sign up for Think Kidneys updates

If you would like to stay informed about the programme's new work and events, fill in the boxes below…

First name*
Last name*
Your email*
CAPTCHA

Stay in touch

Why not follow us, like us, connect with us or just keep in touch?

Facebook Twitter Linked In Youtube Slideshare

AKI Home
About us
Case studies
AKI data
Resources
Glossary
Privacy and terms

© 2025. All rights reserved. UK Renal Registry. Think Kidneys is the brand name for UK Renal Registry’s NHS programmes
UK Renal Registry is part of the Renal Association. The Renal Association is a charitable Company Limited by Guarantee No. 800733 Registered in England No. 2229663

Back to top